Susquehanna International Group
BMGL

Susquehanna International Group’s Basel Medical BMGL Stock Holding History

Susquehanna International Group’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,274
Closed -$7.49K – 14438
2025
Q4 		$7.49K Buy
+1,274
New +$18.8K ﹤0.01% 12077

Other funds holding BMGL

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's BMGL Position: Q1 2026 in Review

Susquehanna International Group sold out of Basel Medical (BMGL) in Q1 2026, closing a stake of 1,274 shares — an estimated $7.49K sold.

Susquehanna International Group first reported a position in BMGL in Q4 2025 and held it in 1 quarter. The position peaked at $7.49K in Q4 2025. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

  • Susquehanna International Group reported no remaining Basel Medical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,274 Basel Medical shares in Q1 2026, an estimated $7.49K.
  • Susquehanna International Group first reported a position in Basel Medical in Q4 2025 and held it in 1 quarter.
  • Susquehanna International Group's Basel Medical position peaked at $7.49K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.